世界のリキッドバイオプシー用循環バイオマーカー市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Circulating Biomarker for Liquid Biopsy Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z1336 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、リキッドバイオプシー用循環バイオマーカーのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（循環腫瘍細胞（CTC）、循環腫瘍DNA（ctDNA）、無細胞DNA（cfDNA）、細胞外小胞（EV）、その他）、用途別市場規模（早期がん検診、治療法選択、治療モニタリング、再発モニタリング整形外科）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・リキッドバイオプシー用循環バイオマーカーの市場動向 ・企業の競争状況、市場シェア ・リキッドバイオプシー用循環バイオマーカーの種類別市場規模（循環腫瘍細胞（CTC）、循環腫瘍DNA（ctDNA）、無細胞DNA（cfDNA）、細胞外小胞（EV）、その他） ・リキッドバイオプシー用循環バイオマーカーの用途別市場規模（早期がん検診、治療法選択、治療モニタリング、再発モニタリング整形外科） ・リキッドバイオプシー用循環バイオマーカーの北米市場規模2016-2027（アメリカ、カナダ） ・リキッドバイオプシー用循環バイオマーカーのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・リキッドバイオプシー用循環バイオマーカーのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・リキッドバイオプシー用循環バイオマーカーの中南米市場規模2016-2027（メキシコ、ブラジル） ・リキッドバイオプシー用循環バイオマーカーの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abbott Laboratories、Becton, Dickinson and Company、GE Healthcare、Epigenomics AG、Agilent Technologies、Biocept、Affymetrix、Fluxion Biosciences） ・結論

Market Analysis and Insights: Global Circulating Biomarker for Liquid Biopsy Market
The global Circulating Biomarker for Liquid Biopsy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Circulating Biomarker for Liquid Biopsy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Circulating Biomarker for Liquid Biopsy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Circulating Biomarker for Liquid Biopsy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Circulating Biomarker for Liquid Biopsy market.

Global Circulating Biomarker for Liquid Biopsy Scope and Market Size
Circulating Biomarker for Liquid Biopsy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Circulating Biomarker for Liquid Biopsy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Circulating Tumor Cells (CTCs)
Circulating Tumor DNA (ctDNA)
Cell-Free DNA (cfDNA)
Extracellular Vesicles (EVs)
Others

Segment by Application
Early Cancer Screening
Therapy Selection
Treatment Monitoring
Recurrence Monitoring Orthopedics

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Abbott Laboratories
Becton, Dickinson and Company
GE Healthcare
Epigenomics AG
Agilent Technologies
Biocept
Affymetrix
Fluxion Biosciences

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Circulating Biomarker for Liquid Biopsy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Circulating Tumor Cells (CTCs)
1.2.3 Circulating Tumor DNA (ctDNA)
1.2.4 Cell-Free DNA (cfDNA)
1.2.5 Extracellular Vesicles (EVs)
1.2.6 Others
1.3 Market by Application
1.3.1 Global Circulating Biomarker for Liquid Biopsy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Early Cancer Screening
1.3.3 Therapy Selection
1.3.4 Treatment Monitoring
1.3.5 Recurrence Monitoring Orthopedics
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Circulating Biomarker for Liquid Biopsy Market Perspective (2016-2027)
2.2 Circulating Biomarker for Liquid Biopsy Growth Trends by Regions
2.2.1 Circulating Biomarker for Liquid Biopsy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Circulating Biomarker for Liquid Biopsy Historic Market Share by Regions (2016-2021)
2.2.3 Circulating Biomarker for Liquid Biopsy Forecasted Market Size by Regions (2022-2027)
2.3 Circulating Biomarker for Liquid Biopsy Industry Dynamic
2.3.1 Circulating Biomarker for Liquid Biopsy Market Trends
2.3.2 Circulating Biomarker for Liquid Biopsy Market Drivers
2.3.3 Circulating Biomarker for Liquid Biopsy Market Challenges
2.3.4 Circulating Biomarker for Liquid Biopsy Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Circulating Biomarker for Liquid Biopsy Players by Revenue
3.1.1 Global Top Circulating Biomarker for Liquid Biopsy Players by Revenue (2016-2021)
3.1.2 Global Circulating Biomarker for Liquid Biopsy Revenue Market Share by Players (2016-2021)
3.2 Global Circulating Biomarker for Liquid Biopsy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Circulating Biomarker for Liquid Biopsy Revenue
3.4 Global Circulating Biomarker for Liquid Biopsy Market Concentration Ratio
3.4.1 Global Circulating Biomarker for Liquid Biopsy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Circulating Biomarker for Liquid Biopsy Revenue in 2020
3.5 Circulating Biomarker for Liquid Biopsy Key Players Head office and Area Served
3.6 Key Players Circulating Biomarker for Liquid Biopsy Product Solution and Service
3.7 Date of Enter into Circulating Biomarker for Liquid Biopsy Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Circulating Biomarker for Liquid Biopsy Breakdown Data by Type
4.1 Global Circulating Biomarker for Liquid Biopsy Historic Market Size by Type (2016-2021)
4.2 Global Circulating Biomarker for Liquid Biopsy Forecasted Market Size by Type (2022-2027)

5 Circulating Biomarker for Liquid Biopsy Breakdown Data by Application
5.1 Global Circulating Biomarker for Liquid Biopsy Historic Market Size by Application (2016-2021)
5.2 Global Circulating Biomarker for Liquid Biopsy Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Circulating Biomarker for Liquid Biopsy Market Size (2016-2027)
6.2 North America Circulating Biomarker for Liquid Biopsy Market Size by Type
6.2.1 North America Circulating Biomarker for Liquid Biopsy Market Size by Type (2016-2021)
6.2.2 North America Circulating Biomarker for Liquid Biopsy Market Size by Type (2022-2027)
6.2.3 North America Circulating Biomarker for Liquid Biopsy Market Size by Type (2016-2027)
6.3 North America Circulating Biomarker for Liquid Biopsy Market Size by Application
6.3.1 North America Circulating Biomarker for Liquid Biopsy Market Size by Application (2016-2021)
6.3.2 North America Circulating Biomarker for Liquid Biopsy Market Size by Application (2022-2027)
6.3.3 North America Circulating Biomarker for Liquid Biopsy Market Size by Application (2016-2027)
6.4 North America Circulating Biomarker for Liquid Biopsy Market Size by Country
6.4.1 North America Circulating Biomarker for Liquid Biopsy Market Size by Country (2016-2021)
6.4.2 North America Circulating Biomarker for Liquid Biopsy Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Circulating Biomarker for Liquid Biopsy Market Size (2016-2027)
7.2 Europe Circulating Biomarker for Liquid Biopsy Market Size by Type
7.2.1 Europe Circulating Biomarker for Liquid Biopsy Market Size by Type (2016-2021)
7.2.2 Europe Circulating Biomarker for Liquid Biopsy Market Size by Type (2022-2027)
7.2.3 Europe Circulating Biomarker for Liquid Biopsy Market Size by Type (2016-2027)
7.3 Europe Circulating Biomarker for Liquid Biopsy Market Size by Application
7.3.1 Europe Circulating Biomarker for Liquid Biopsy Market Size by Application (2016-2021)
7.3.2 Europe Circulating Biomarker for Liquid Biopsy Market Size by Application (2022-2027)
7.3.3 Europe Circulating Biomarker for Liquid Biopsy Market Size by Application (2016-2027)
7.4 Europe Circulating Biomarker for Liquid Biopsy Market Size by Country
7.4.1 Europe Circulating Biomarker for Liquid Biopsy Market Size by Country (2016-2021)
7.4.2 Europe Circulating Biomarker for Liquid Biopsy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Circulating Biomarker for Liquid Biopsy Market Size (2016-2027)
8.2 Asia-Pacific Circulating Biomarker for Liquid Biopsy Market Size by Type
8.2.1 Asia-Pacific Circulating Biomarker for Liquid Biopsy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Circulating Biomarker for Liquid Biopsy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Circulating Biomarker for Liquid Biopsy Market Size by Type (2016-2027)
8.3 Asia-Pacific Circulating Biomarker for Liquid Biopsy Market Size by Application
8.3.1 Asia-Pacific Circulating Biomarker for Liquid Biopsy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Circulating Biomarker for Liquid Biopsy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Circulating Biomarker for Liquid Biopsy Market Size by Application (2016-2027)
8.4 Asia-Pacific Circulating Biomarker for Liquid Biopsy Market Size by Region
8.4.1 Asia-Pacific Circulating Biomarker for Liquid Biopsy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Circulating Biomarker for Liquid Biopsy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Circulating Biomarker for Liquid Biopsy Market Size (2016-2027)
9.2 Latin America Circulating Biomarker for Liquid Biopsy Market Size by Type
9.2.1 Latin America Circulating Biomarker for Liquid Biopsy Market Size by Type (2016-2021)
9.2.2 Latin America Circulating Biomarker for Liquid Biopsy Market Size by Type (2022-2027)
9.2.3 Latin America Circulating Biomarker for Liquid Biopsy Market Size by Type (2016-2027)
9.3 Latin America Circulating Biomarker for Liquid Biopsy Market Size by Application
9.3.1 Latin America Circulating Biomarker for Liquid Biopsy Market Size by Application (2016-2021)
9.3.2 Latin America Circulating Biomarker for Liquid Biopsy Market Size by Application (2022-2027)
9.3.3 Latin America Circulating Biomarker for Liquid Biopsy Market Size by Application (2016-2027)
9.4 Latin America Circulating Biomarker for Liquid Biopsy Market Size by Country
9.4.1 Latin America Circulating Biomarker for Liquid Biopsy Market Size by Country (2016-2021)
9.4.2 Latin America Circulating Biomarker for Liquid Biopsy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Size (2016-2027)
10.2 Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Size by Type
10.2.1 Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Size by Type (2016-2027)
10.3 Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Size by Application
10.3.1 Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Size by Application (2016-2027)
10.4 Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Size by Country
10.4.1 Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Circulating Biomarker for Liquid Biopsy Introduction
11.1.4 Abbott Laboratories Revenue in Circulating Biomarker for Liquid Biopsy Business (2016-2021)
11.1.5 Abbott Laboratories Recent Development
11.2 Becton, Dickinson and Company
11.2.1 Becton, Dickinson and Company Company Details
11.2.2 Becton, Dickinson and Company Business Overview
11.2.3 Becton, Dickinson and Company Circulating Biomarker for Liquid Biopsy Introduction
11.2.4 Becton, Dickinson and Company Revenue in Circulating Biomarker for Liquid Biopsy Business (2016-2021)
11.2.5 Becton, Dickinson and Company Recent Development
11.3 GE Healthcare
11.3.1 GE Healthcare Company Details
11.3.2 GE Healthcare Business Overview
11.3.3 GE Healthcare Circulating Biomarker for Liquid Biopsy Introduction
11.3.4 GE Healthcare Revenue in Circulating Biomarker for Liquid Biopsy Business (2016-2021)
11.3.5 GE Healthcare Recent Development
11.4 Epigenomics AG
11.4.1 Epigenomics AG Company Details
11.4.2 Epigenomics AG Business Overview
11.4.3 Epigenomics AG Circulating Biomarker for Liquid Biopsy Introduction
11.4.4 Epigenomics AG Revenue in Circulating Biomarker for Liquid Biopsy Business (2016-2021)
11.4.5 Epigenomics AG Recent Development
11.5 Agilent Technologies
11.5.1 Agilent Technologies Company Details
11.5.2 Agilent Technologies Business Overview
11.5.3 Agilent Technologies Circulating Biomarker for Liquid Biopsy Introduction
11.5.4 Agilent Technologies Revenue in Circulating Biomarker for Liquid Biopsy Business (2016-2021)
11.5.5 Agilent Technologies Recent Development
11.6 Biocept
11.6.1 Biocept Company Details
11.6.2 Biocept Business Overview
11.6.3 Biocept Circulating Biomarker for Liquid Biopsy Introduction
11.6.4 Biocept Revenue in Circulating Biomarker for Liquid Biopsy Business (2016-2021)
11.6.5 Biocept Recent Development
11.7 Affymetrix
11.7.1 Affymetrix Company Details
11.7.2 Affymetrix Business Overview
11.7.3 Affymetrix Circulating Biomarker for Liquid Biopsy Introduction
11.7.4 Affymetrix Revenue in Circulating Biomarker for Liquid Biopsy Business (2016-2021)
11.7.5 Affymetrix Recent Development
11.8 Fluxion Biosciences
11.8.1 Fluxion Biosciences Company Details
11.8.2 Fluxion Biosciences Business Overview
11.8.3 Fluxion Biosciences Circulating Biomarker for Liquid Biopsy Introduction
11.8.4 Fluxion Biosciences Revenue in Circulating Biomarker for Liquid Biopsy Business (2016-2021)
11.8.5 Fluxion Biosciences Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Circulating Biomarker for Liquid Biopsy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Circulating Tumor Cells (CTCs)
Table 3. Key Players of Circulating Tumor DNA (ctDNA)
Table 4. Key Players of Cell-Free DNA (cfDNA)
Table 5. Key Players of Extracellular Vesicles (EVs)
Table 6. Key Players of Others
Table 7. Global Circulating Biomarker for Liquid Biopsy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Circulating Biomarker for Liquid Biopsy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Circulating Biomarker for Liquid Biopsy Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Circulating Biomarker for Liquid Biopsy Market Share by Regions (2016-2021)
Table 11. Global Circulating Biomarker for Liquid Biopsy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Circulating Biomarker for Liquid Biopsy Market Share by Regions (2022-2027)
Table 13. Circulating Biomarker for Liquid Biopsy Market Trends
Table 14. Circulating Biomarker for Liquid Biopsy Market Drivers
Table 15. Circulating Biomarker for Liquid Biopsy Market Challenges
Table 16. Circulating Biomarker for Liquid Biopsy Market Restraints
Table 17. Global Circulating Biomarker for Liquid Biopsy Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Circulating Biomarker for Liquid Biopsy Market Share by Players (2016-2021)
Table 19. Global Top Circulating Biomarker for Liquid Biopsy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Circulating Biomarker for Liquid Biopsy as of 2020)
Table 20. Ranking of Global Top Circulating Biomarker for Liquid Biopsy Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Circulating Biomarker for Liquid Biopsy Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Circulating Biomarker for Liquid Biopsy Product Solution and Service
Table 24. Date of Enter into Circulating Biomarker for Liquid Biopsy Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Circulating Biomarker for Liquid Biopsy Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Circulating Biomarker for Liquid Biopsy Revenue Market Share by Type (2016-2021)
Table 28. Global Circulating Biomarker for Liquid Biopsy Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Circulating Biomarker for Liquid Biopsy Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Circulating Biomarker for Liquid Biopsy Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Circulating Biomarker for Liquid Biopsy Revenue Market Share by Application (2016-2021)
Table 32. Global Circulating Biomarker for Liquid Biopsy Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Circulating Biomarker for Liquid Biopsy Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Circulating Biomarker for Liquid Biopsy Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Circulating Biomarker for Liquid Biopsy Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Circulating Biomarker for Liquid Biopsy Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Circulating Biomarker for Liquid Biopsy Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Circulating Biomarker for Liquid Biopsy Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Circulating Biomarker for Liquid Biopsy Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Circulating Biomarker for Liquid Biopsy Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Circulating Biomarker for Liquid Biopsy Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Circulating Biomarker for Liquid Biopsy Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Circulating Biomarker for Liquid Biopsy Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Circulating Biomarker for Liquid Biopsy Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Circulating Biomarker for Liquid Biopsy Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Circulating Biomarker for Liquid Biopsy Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Circulating Biomarker for Liquid Biopsy Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Circulating Biomarker for Liquid Biopsy Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Circulating Biomarker for Liquid Biopsy Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Circulating Biomarker for Liquid Biopsy Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Circulating Biomarker for Liquid Biopsy Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Circulating Biomarker for Liquid Biopsy Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Circulating Biomarker for Liquid Biopsy Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Circulating Biomarker for Liquid Biopsy Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Circulating Biomarker for Liquid Biopsy Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Circulating Biomarker for Liquid Biopsy Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Circulating Biomarker for Liquid Biopsy Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Size by Country (2022-2027) & (US$ Million)
Table 64. Abbott Laboratories Company Details
Table 65. Abbott Laboratories Business Overview
Table 66. Abbott Laboratories Circulating Biomarker for Liquid Biopsy Product
Table 67. Abbott Laboratories Revenue in Circulating Biomarker for Liquid Biopsy Business (2016-2021) & (US$ Million)
Table 68. Abbott Laboratories Recent Development
Table 69. Becton, Dickinson and Company Company Details
Table 70. Becton, Dickinson and Company Business Overview
Table 71. Becton, Dickinson and Company Circulating Biomarker for Liquid Biopsy Product
Table 72. Becton, Dickinson and Company Revenue in Circulating Biomarker for Liquid Biopsy Business (2016-2021) & (US$ Million)
Table 73. Becton, Dickinson and Company Recent Development
Table 74. GE Healthcare Company Details
Table 75. GE Healthcare Business Overview
Table 76. GE Healthcare Circulating Biomarker for Liquid Biopsy Product
Table 77. GE Healthcare Revenue in Circulating Biomarker for Liquid Biopsy Business (2016-2021) & (US$ Million)
Table 78. GE Healthcare Recent Development
Table 79. Epigenomics AG Company Details
Table 80. Epigenomics AG Business Overview
Table 81. Epigenomics AG Circulating Biomarker for Liquid Biopsy Product
Table 82. Epigenomics AG Revenue in Circulating Biomarker for Liquid Biopsy Business (2016-2021) & (US$ Million)
Table 83. Epigenomics AG Recent Development
Table 84. Agilent Technologies Company Details
Table 85. Agilent Technologies Business Overview
Table 86. Agilent Technologies Circulating Biomarker for Liquid Biopsy Product
Table 87. Agilent Technologies Revenue in Circulating Biomarker for Liquid Biopsy Business (2016-2021) & (US$ Million)
Table 88. Agilent Technologies Recent Development
Table 89. Biocept Company Details
Table 90. Biocept Business Overview
Table 91. Biocept Circulating Biomarker for Liquid Biopsy Product
Table 92. Biocept Revenue in Circulating Biomarker for Liquid Biopsy Business (2016-2021) & (US$ Million)
Table 93. Biocept Recent Development
Table 94. Affymetrix Company Details
Table 95. Affymetrix Business Overview
Table 96. Affymetrix Circulating Biomarker for Liquid Biopsy Product
Table 97. Affymetrix Revenue in Circulating Biomarker for Liquid Biopsy Business (2016-2021) & (US$ Million)
Table 98. Affymetrix Recent Development
Table 99. Fluxion Biosciences Company Details
Table 100. Fluxion Biosciences Business Overview
Table 101. Fluxion Biosciences Revenue in Circulating Biomarker for Liquid Biopsy Business (2016-2021) & (US$ Million)
Table 102. Fluxion Biosciences Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Circulating Biomarker for Liquid Biopsy Market Share by Type: 2020 VS 2027
Figure 2. Circulating Tumor Cells (CTCs) Features
Figure 3. Circulating Tumor DNA (ctDNA) Features
Figure 4. Cell-Free DNA (cfDNA) Features
Figure 5. Extracellular Vesicles (EVs) Features
Figure 6. Others Features
Figure 7. Global Circulating Biomarker for Liquid Biopsy Market Share by Application: 2020 VS 2027
Figure 8. Early Cancer Screening Case Studies
Figure 9. Therapy Selection Case Studies
Figure 10. Treatment Monitoring Case Studies
Figure 11. Recurrence Monitoring Orthopedics Case Studies
Figure 12. Circulating Biomarker for Liquid Biopsy Report Years Considered
Figure 13. Global Circulating Biomarker for Liquid Biopsy Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Circulating Biomarker for Liquid Biopsy Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Circulating Biomarker for Liquid Biopsy Market Share by Regions: 2020 VS 2027
Figure 16. Global Circulating Biomarker for Liquid Biopsy Market Share by Regions (2022-2027)
Figure 17. Global Circulating Biomarker for Liquid Biopsy Market Share by Players in 2020
Figure 18. Global Top Circulating Biomarker for Liquid Biopsy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Circulating Biomarker for Liquid Biopsy as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Circulating Biomarker for Liquid Biopsy Revenue in 2020
Figure 20. Global Circulating Biomarker for Liquid Biopsy Revenue Market Share by Type (2016-2021)
Figure 21. Global Circulating Biomarker for Liquid Biopsy Revenue Market Share by Type (2022-2027)
Figure 22. North America Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Circulating Biomarker for Liquid Biopsy Market Share by Type (2016-2027)
Figure 24. North America Circulating Biomarker for Liquid Biopsy Market Share by Application (2016-2027)
Figure 25. North America Circulating Biomarker for Liquid Biopsy Market Share by Country (2016-2027)
Figure 26. United States Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Circulating Biomarker for Liquid Biopsy Market Share by Type (2016-2027)
Figure 30. Europe Circulating Biomarker for Liquid Biopsy Market Share by Application (2016-2027)
Figure 31. Europe Circulating Biomarker for Liquid Biopsy Market Share by Country (2016-2027)
Figure 32. Germany Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Circulating Biomarker for Liquid Biopsy Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Circulating Biomarker for Liquid Biopsy Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Circulating Biomarker for Liquid Biopsy Market Share by Region (2016-2027)
Figure 42. China Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Circulating Biomarker for Liquid Biopsy Market Share by Type (2016-2027)
Figure 50. Latin America Circulating Biomarker for Liquid Biopsy Market Share by Application (2016-2027)
Figure 51. Latin America Circulating Biomarker for Liquid Biopsy Market Share by Country (2016-2027)
Figure 52. Mexico Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Share by Country (2016-2027)
Figure 58. Turkey Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Abbott Laboratories Revenue Growth Rate in Circulating Biomarker for Liquid Biopsy Business (2016-2021)
Figure 62. Becton, Dickinson and Company Revenue Growth Rate in Circulating Biomarker for Liquid Biopsy Business (2016-2021)
Figure 63. GE Healthcare Revenue Growth Rate in Circulating Biomarker for Liquid Biopsy Business (2016-2021)
Figure 64. Epigenomics AG Revenue Growth Rate in Circulating Biomarker for Liquid Biopsy Business (2016-2021)
Figure 65. Agilent Technologies Revenue Growth Rate in Circulating Biomarker for Liquid Biopsy Business (2016-2021)
Figure 66. Biocept Revenue Growth Rate in Circulating Biomarker for Liquid Biopsy Business (2016-2021)
Figure 67. Affymetrix Revenue Growth Rate in Circulating Biomarker for Liquid Biopsy Business (2016-2021)
Figure 68. Fluxion Biosciences Revenue Growth Rate in Circulating Biomarker for Liquid Biopsy Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

---